 double-blind gastroscop evalu effect etodolac naproxen gastrointestin mucosa rheumat patient aim clinic endoscop studi therapeut efficaci gastric toler etodolac new anti-inflammatori non-steroid drug naproxen studi patient rheumatoid arthriti trial initi oesophagogastroduodenoscopi presenc gastric mucos lesion patient treatment etodolac mg b.i.d naproxen mg b.i.d period week endoscop control treatment period drug effect clinic symptom signific differ gastric mucos lesion etodolac-tr patient patient naproxen CI pain dyspepsia patient etodolac patient naproxen therapi studi etodolac activ naproxen rheumat symptom administr result degre gastric damag